Literature DB >> 9364687

Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci.

E R Brandt1, W A Hayman, B Currie, S Pruksakorn, M F Good.   

Abstract

A 20-mer peptide (p145) in the carboxyl-terminal region of the M protein of group A streptococci (GAS) has previously been defined as the target of bactericidal antibodies. Sequence analysis of seven field isolates from indigenous Australians living in an area highly endemic for GAS and five laboratory reference strains (encompassing nine unique serotypes plus three nontypeables) demonstrates that this region is highly conserved (sequence identity ranging from 65 to 95%) with six of the 12 sequences being identical to p145. Most of the sequence dissimilarity is contained within the last seven amino acids of p145. Competitive ELISA demonstrates that human antibodies specific for p145 cannot discriminate between p145 and synthetic peptides representing four from four of the variant sequences tested. Ig purified from endemic sera was able to opsonize each of the GAS isolates and free p145 as well as a peptide expressing a minimal conformational epitope within p145 (requiring amino acids between positions 2 and 13 of p145), but not an irrelevant peptide, were able to partially or completely inhibit opsonization of all isolates and reference strains. Thus adult endemic sera contain antibodies which are bactericidal for multiple GAS serotypes and which are specific for a sequence of 12 amino acids contained within the p145 region of the M protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364687     DOI: 10.1016/s0264-410x(97)00178-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.

Authors:  E R Brandt; T Teh; W A Relf; R I Hobb; M F Good
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

Authors:  Mary A Hall; Steven D Stroop; Mary C Hu; Michael A Walls; Mark A Reddish; David S Burt; George H Lowell; James B Dale
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 3.  Strategies in the development of vaccines to prevent infections with group A streptococcus.

Authors:  Michael F Good; Michael R Batzloff; Manisha Pandey
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

4.  The prospect of vaccination against group A beta-hemolytic streptococci.

Authors:  Karen L Kotloff
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

5.  Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate.

Authors:  Michael R Batzloff; Anne Fane; Davina Gorton; Manisha Pandey; Tania Rivera-Hernandez; Ainslie Calcutt; Grace Yeung; Jon Hartas; Linda Johnson; Catherine M Rush; James McCarthy; Natkunam Ketheesan; Michael F Good
Journal:  Hum Vaccin Immunother       Date:  2016-08-19       Impact factor: 3.452

6.  Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

Authors:  Colleen Olive; Michael Batzloff; Aniko Horváth; Timothy Clair; Penny Yarwood; Istvan Toth; Michael F Good
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  Immunogenicity of a divalent group A streptococcal vaccine.

Authors:  Yuexia Ding; Qiongqiong Ni; Jinlai Liu; Buyun Yu
Journal:  Rheumatol Int       Date:  2012-08-08       Impact factor: 2.631

Review 8.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

9.  Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease.

Authors:  Davina Gorton; Suchandan Sikder; Natasha L Williams; Lisa Chilton; Catherine M Rush; Brenda L Govan; Madeleine W Cunningham; Natkunam Ketheesan
Journal:  Autoimmunity       Date:  2016-08-25       Impact factor: 2.815

10.  B- and T-cell responses in group a streptococcus M-protein- or Peptide-induced experimental carditis.

Authors:  Davina Gorton; Brenda Govan; Colleen Olive; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.